An international arbitration tribunal rules for Finnegan client on inventorship and contract interpretation disputes

A major European research institute, represented by Finnegan, has been embroiled in a three year dispute with a major U.S. pharmaceutical company involving patent inventorship and contract interpretation issues. The three-member arbitration panel has ruled in favor of our client which is now entitled to increased license fees from the pharmaceutical partner.